INTERNATIONAL PATENT: BIOCRYST PHARMACEUTICALS, INC. FILES APPLICATION FOR "ANTI-C2 BINDING AGENTS AND CONJUGATES THEREOF"

GENEVA, May 15 -- BIOCRYST PHARMACEUTICALS, INC. (4505 Emperor Blvd.Suite 200Durham, NC 27703) filed a patent application (PCT/US2024/054068) for "ANTI-C2 BINDING AGENTS AND CONJUGATES THEREOF" on Nov 01, 2024. With publication no. WO/2025/096903, the details related to the patent application was published on May 08, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BABU, Yarlagadda, S. (4836 Southlake ParkwayBirmingham, AL 35244), CHEN, Xilin (1695 Ridge Haven RunAlpharetta, GA 30022), WU, Mousheng (1210 Buckhead CircleVestavia Hills, AL 35216), MA, Yuanyuan, X. (2628 Crossgate LaneVestavia H...